ArticlePloS one2014

Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel.

Qian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.